Biggest News Aggregation in the World

Yonsei Severance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yonsei Severance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yonsei Severance Today - Breaking & Trending Today

$Genexine reports encouraging top-line results of the Phase 1b/2 clinical trial with GX-I7 (efineptakin alfa) in refractory or recurrent (R/R) metastatic Triple Negative Breast Cancer - Vimarsana News$

Genexine reports encouraging top-line results of the Phase 1b/2 clinical trial with GX-I7 (efineptakin alfa) in refractory or recurrent (R/R) metastatic Triple Negative Breast Cancer

Published: June 7, 2022

SEOUL, South Korea--(BUSINESS WIRE)--Jun 7, 2022--

Source: wsiltv.com